SLINDA 4 mg, film-coated tablet 72 tablets
Active ingredients: Drospirenone
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet72 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SLINDA 4 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 3 plaquettes calendaires en PVC PVDC aluminium de 24 comprimés blancs (actifs) et 4 comprimés verts (placebo)
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 13 Jan 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68971188CIP73019275CIP133400930192757Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DROSPIRÉNONEcomprimé blanc | 4 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.